Clinical Trial: A Study to Assess the Safety and Efficacy of AGN-151586 Injections for the Treatment of Moderate to Severe Forehead Lines (FHL) in Adult Participants

U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07730554) titled 'A Study to Assess the Safety and Efficacy of AGN-151586 Injections for the Treatment of Moderate to Severe Forehead Lines (FHL) in Adult Participants' on July 23.

Brief Summary: The objective of this study is to evaluate the safety and efficacy of AGN-151586 for the treatment of moderate to severe forehead lines (FHL) in adult participants.

Study Start Date: July 28

Study Type: INTERVENTIONAL

Condition: Forehead Lines

Intervention: DRUG: AGN-151586

Injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AbbVie

Published by HT Digital Content Services with permission from Health Daily Digest....